Grifols Company

A company focused on the research, development, production and commercialization of plasma-derived medicines. They also supply high-quality biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. They are also involved in the research, development, production and commercialization of diagnostic products.

Funding Status: IPO
Headquarters: Spain
Founded Date: 1940-01-01
Investor Type: N/A
Investment Stage: N/A
Technology: COVID
Employee Number: 10001+
Number Of Exists: 2
Estimated Revenue: $1B to $10B
Industry: Longevity